Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
In-Vitro Transcription Templates Market Size And Revenue Outlook Through 2030
The in-vitro transcription templates market has shown substantial growth in recent years. Its valuation is anticipated to climb from $1.24 billion in 2025 to $1.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.0%. The expansion observed in the past can be attributed to the widespread use of in-vitro transcription in molecular biology research, the early adoption of rna synthesis tools in academic laboratories, the growth of gene expression and functional genomics studies, the availability of standardized dna template design methods, and the expansion of biotech research infrastructure.
The in-vitro transcription templates market size is expected to experience substantial expansion in the coming years. It will grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. This growth during the forecast period is primarily driven by the ongoing development in mRNA vaccine pipelines, increased financial commitments towards RNA-based therapeutics, the escalating need for rapid and scalable RNA production platforms, the broadening scope of clinical-stage genetic therapies, and the increasing requirement for high-quality templates in regulated manufacturing. Key trends identified for the forecast timeframe involve an escalating need for in-vitro transcription templates in mRNA vaccine creation, the increased adoption of high-fidelity templates for RNA-based therapeutics, a growing inclination for custom and sequence-specific transcription templates, the widening application of in-vitro transcription templates in diagnostic assay development, and a stronger emphasis on scalable and GMP-grade template production.
Get A Free Sample Report With In-Depth Market Insights:
In-Vitro Transcription Templates Market Demand Drivers: What’s Powering Industry Growth?
The future expansion of the in-vitro transcription templates market is anticipated to be driven by the growing emphasis on gene therapy. Gene therapy involves medical methods aimed at altering or substituting genes within cells to manage or avert illnesses by rectifying genetic defects. This heightened interest in gene therapy stems from progress in technologies like CRISPR, rising financial commitments, an expanding array of research projects, and positive results from clinical trials. The in-vitro transcription templates market plays a crucial role in supporting gene therapy through the provision of RNA molecules vital for mRNA therapeutics, siRNA treatments, and gene-editing applications, thereby facilitating the creation of precise therapies for both inherited and acquired conditions. As an illustration, in March 2024, the U.S. Food and Drug Administration (FDA), a US-based federal agency, reported that 36 gene therapies had received approval, with more than 500 additional therapies under development, and an estimated 10–20 new approvals projected each year by 2025. Consequently, the escalating focus on gene therapy is boosting the growth of the in-vitro transcription templates market.
In-Vitro Transcription Templates Market Segment Landscape: Which Areas Lead Development?
The in-vitro transcription templates market covered in this report is segmented –
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage: Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users
Subsegments:
1) By Vaccine: MRNA Vaccines, DNA Vaccines
2) By Therapeutic: Gene Therapy, RNA-Based Therapeutics
In-Vitro Transcription Templates Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies active in the in-vitro transcription templates market are prioritizing the development of self-amplifying RNA (saRNA) synthesis services. This focus is aimed at improving the efficiency of RNA therapy, reducing manufacturing expenses, and enhancing the capabilities of next-generation genetic medicines. Self-amplifying RNA synthesis services describe technologies that create RNA molecules designed to replicate themselves within host cells, which allows for substantial protein expression from minimal RNA input and consequently boosts the potency and efficacy of RNA-based vaccines, immunotherapies, and gene therapies. For instance, in May 2024, GenScript Biotech Corporation, a US-based biotechnology company, introduced its self-amplifying RNA (saRNA) synthesis service as part of its broadened in-vitro transcription RNA portfolio. This service provides high-purity saRNA intended to deliver robust protein expression, support lower dosing requirements, decrease production costs, and improve therapeutic outcomes across various RNA-based applications.
In-Vitro Transcription Templates Market Industry Leaders And Competitive Landscape
Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Synthego Corporation, Synbio Technologies, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia
View The Full In-Vitro Transcription Templates Market Report:
In-Vitro Transcription Templates Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the in-vitro transcription templates market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro transcription templates market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model